References
- Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2017;70:252-89. https://doi.org/10.1016/j.jacc.2017.03.011
- Svensson LG, Adams DH, Bonow RO, et al. Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg 2013;95(6 Suppl):S1-66. https://doi.org/10.1016/j.athoracsur.2013.01.083
- Dunning J, Gao H, Chambers J, et al. Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use: an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg 2011;142:776-82.
- Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82-90. https://doi.org/10.1016/j.jtcvs.2008.08.015
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91. https://doi.org/10.1093/eurheartj/ehx391
- Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28: 230-68.
- Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012;380:2144-62.
- Ashikhmina EA, Schaff HV, Dearani JA, et al. Aortic valve replacement in the elderly: determinants of late outcome. Circulation 2011;124:1070-8. https://doi.org/10.1161/CIRCULATIONAHA.110.987560
- Brown ML, Schaff HV, Lahr BD, et al. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg 2008;135:878-84. https://doi.org/10.1016/j.jtcvs.2007.10.065
- Stassano P, Di Tommaso L, Monaco M, et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol 2009;54:1862-8.
- Vicchio M, Della Corte A, De Santo LS, et al. Tissue versus mechanical prostheses: quality of life in octogenarians. Ann Thorac Surg 2008;85:1290-5. https://doi.org/10.1016/j.athoracsur.2007.12.039
- Weber A, Noureddine H, Englberger L, et al. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age. J Thorac Cardiovasc Surg 2012; 144:1075-83. https://doi.org/10.1016/j.jtcvs.2012.01.024
- Brennan JM, Edwards FH, Zhao Y, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation 2013;127:1647-55. https://doi.org/10.1161/CIRCULATIONAHA.113.002003
- Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008;85:1490-5. https://doi.org/10.1016/j.athoracsur.2007.12.082
- Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. https://doi.org/10.1016/j.echo.2005.10.005
- Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-8.
- Kobayashi J. Changing strategy for aortic stenosis by transcatheter valve treatment in Japan. Circ J 2013;77: 309-10.
- Maeda K, Kuratani T, Mizote I, et al. Early experiences of transcatheter aortic valve replacement in Japan. Circ J 2013;77:359-62. https://doi.org/10.1253/circj.CJ-12-0650
- Accola KD, Scott ML, Palmer GJ, et al. Surgical management of aortic valve disease in the elderly: a retrospective comparative study of valve choice using propensity score analysis. J Heart Valve Dis 2008;17:355-64.
- De Vincentiis C, Kunkl AB, Trimarchi S, et al. Aortic valve replacement in octogenarians: is biologic valve the unique solution? Ann Thorac Surg 2008;85:1296-301.
- Kurlansky PA, Williams DB, Traad EA, et al. The valve of choice in elderly patients and its influence on quality of life: a long-term comparative study. J Heart Valve Dis 2006;15:180-9.
- Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg 2006;132:20-6.
- Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb-warfarin interactions. Evid Based Complement Alternat Med 2014;2014:957362.
- Said SM, Ashikhmina E, Greason KL, et al. Do pericardial bioprostheses improve outcome of elderly patients undergoing aortic valve replacement? Ann Thorac Surg 2012;93:1868-74. https://doi.org/10.1016/j.athoracsur.2012.01.061
- McClure RS, Narayanasamy N, Wiegerinck E, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010;89:1410-6. https://doi.org/10.1016/j.athoracsur.2010.01.046
- Farivar RS, Cohn LH. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg 2003;126:969-75. https://doi.org/10.1016/S0022-5223(03)00708-6
- Antonini-Canterin F, Zuppiroli A, Popescu BA, et al. Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol 2003;92:1479-82. https://doi.org/10.1016/j.amjcard.2003.08.066
- Dalmau MJ, Gonzalez-Santos JM, Blazquez JA, et al. Hemodynamic performance of the Medtronic Mosaic and Perimount Magna aortic bioprostheses: five-year results of a prospectively randomized study. Eur J Cardiothorac Surg 2011;39:844-52. https://doi.org/10.1016/j.ejcts.2010.11.015
- Okamura H, Yamaguchi A, Yoshizaki T, et al. Clinical outcomes and hemodynamics of the 19-mm Perimount Magna bioprosthesis in an aortic position: comparison with the 19-mm Medtronic Mosaic Ultra Valve. Circ J 2012;76: 102-8. https://doi.org/10.1253/circj.CJ-11-0728
- Yang S, Khang YH, Harper S, Davey Smith G, Leon DA, Lynch J. Understanding the rapid increase in life expectancy in South Korea. Am J Public Health 2010;100:896-903. https://doi.org/10.2105/AJPH.2009.160341
- Khoo JP, Davies JE, Ang KL, Galinanes M, Chin DT. Differences in performance of five types of aortic valve prostheses: haemodynamic assessment by dobutamine stress echocardiography. Heart 2013;99:41-7. https://doi.org/10.1136/heartjnl-2012-302256